Cipla LtdNSE: CIPLA

Press Release Jun 29 2021

· Issued by Cipla Ltd

Filed with NSE · · 4 pages · English

Summary by 6ix AI

This initiative marks a significant first within the Indian pharmaceutical industry, as the companies will jointly sponsor and monitor the trial. The trial is expected to take place over several months, following approval from regulatory authorities.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Cipla Limited has informed the Exchange regarding a press release dated Jun 29, 2021, titled "Cipla, Dr. Reddy s, Emcure, Sun Pharma and Torrent to collaborate for clinical trial of investigational anti-viral drug Molnupiravir for COVID-19 ".

Cipla Ltd on 6ix

Earlier from Cipla

Later from Cipla

All Cipla news releases